Frontlight ResearchEarly access
Trial site
Fundacion Onkologikoa Fundazioa
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Melanoma6 trials
- Childhood cancers4 trials
- Metastatic breast cancer3 trials
- Triple-negative breast cancer2 trials
- Brain metastases1 trial
- Lung cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Lead sponsor
- Merck Sharp & Dohme LLC4 trials
- Bristol-Myers Squibb2 trials
- MedSIR2 trials
- Cantargia AB1 trial
- Grupo Español Multidisciplinar de Melanoma1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Active, not recruiting
Active, not recruiting
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma3 recruiting
- Brain metastases1 recruiting
- Childhood cancers1 recruiting
Closed trials
Active, not recruiting
Completed
Clinical trial of MK-7648A in adults and children with skin cancer
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026